Tarsus Pharmaceuticals's three largest insider shareholders as of September 29, 2026 are Capital Ix, Llc Vivo (TenPercentOwner, 2.47Mn shares), Michael Ackermann (Director, 1.21Mn shares), Bobak R. Azamian (President/Ceo And Board Chair, 827.99K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Capital Ix, Llc Vivo | TenPercentOwner | 0 | 2,469,001 | 2,469,001 | 49.3% | 05 May, 2022 |
| 2 | Michael Ackermann | Director | 1,208,273 | 0 | 1,208,273 | 24.1% | 17 Jun, 2022 |
| 3 | Bobak R. Azamian | President/Ceo And Board Chair | 0 | 827,991 | 827,991 | 16.5% | 09 Sep, 2026 |
| 4 | William J Phd Link | Director | 94,487 | 0 | 94,487 | 1.9% | 17 Sep, 2026 |
| 5 | Seshadri Neervannan | Chief Operating Officer | 78,532 | 0 | 78,532 | 1.6% | 09 Sep, 2026 |
| 6 | Bryan Wahl | General Counsel | 63,959 | 0 | 63,959 | 1.3% | 19 Mar, 2026 |
| 7 | Aziz Mottiwala | Chief Commercial Officer | 61,480 | 0 | 61,480 | 1.2% | 19 Mar, 2026 |
| 8 | Jeffrey S Farrow | Officer | 56,801 | 0 | 56,801 | 1.1% | 17 Jun, 2026 |
| 9 | Dianne C. Whitfield | Chief Human Resources Officer | 35,028 | 0 | 35,028 | 0.7% | 19 Mar, 2026 |
| 10 | Leonard M. Greenstein | Chief Financial Officer | 26,785 | 0 | 26,785 | 0.5% | 21 Apr, 2023 |
| 11 | Andrew D. Goldberg | Director | 19,654 | 0 | 19,654 | 0.4% | 16 Jun, 2026 |
| 12 | Wendy L Yarno | Director | 16,956 | 0 | 16,956 | 0.3% | 17 Sep, 2026 |
| 13 | Bhaskar Chaudhuri | Director | 11,654 | 0 | 11,654 | 0.2% | 16 Jun, 2026 |
| 14 | David E I Pyott | Director | 0 | 9,575 | 9,575 | 0.2% | 17 Sep, 2026 |
| 15 | Scott W Morrison | Director | 7,638 | 0 | 7,638 | 0.2% | 16 Jun, 2026 |
| 16 | Rosemary A Crane | Director | 5,350 | 0 | 5,350 | 0.1% | 25 Jun, 2024 |
| 17 | Elizabeth Yeu Lin | Chief Medical Officer | 2,547 | 1,590 | 4,137 | 0.1% | 09 Sep, 2026 |
| 18 | Mark J. Holdbrook | V.P., Clinical Affairs | 3,191 | 0 | 3,191 | 0.1% | 21 Mar, 2023 |
| 19 | Jose M. Trevejo | Chief Medical Officer | 2,251 | 0 | 2,251 | 0.0% | 22 Dec, 2023 |
| 20 | Katherine Goodrich | Director | 2,233 | 0 | 2,233 | 0.0% | 17 Jun, 2026 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 15 Sep, 2026 | William J Phd Link | Director | Acquired M | 201 | — | — | 106,987 | Direct |
| 15 Sep, 2026 | David E I Pyott | Director | Acquired M | 201 | — | — | 9,575 | Indirect |
| 15 Sep, 2026 | Wendy L Yarno | Director | Acquired M | 302 | — | — | 16,956 | Direct |
| 15 Sep, 2026 | David E I Pyott | Director | Disposed M | 201 | $0.00 | $0 | 605 | Direct |
| 15 Sep, 2026 | William J Phd Link | Director | Disposed S | 11,675 | $78.33 | $914.50K | 95,312 | Direct |
| 15 Sep, 2026 | Wendy L Yarno | Director | Disposed M | 302 | $0.00 | $0 | 907 | Direct |
| 15 Sep, 2026 | William J Phd Link | Director | Disposed S | 759 | $79.00 | $59.96K | 94,553 | Direct |
| 15 Sep, 2026 | William J Phd Link | Director | Disposed S | 66 | $80.01 | $5.28K | 94,487 | Direct |
| 15 Sep, 2026 | William J Phd Link | Director | Disposed M | 201 | $0.00 | $0 | 605 | Direct |
| 04 Sep, 2026 | Elizabeth Yeu Lin | Chief Medical Officer | Disposed S | 5,387 | $85.00 | $457.90K | 7,933 | Direct |
| 04 Sep, 2026 | Bobak R. Azamian | President/Ceo And Board Chair | Disposed S | 7,100 | $90.27 | $640.92K | 830,891 | Indirect |
| 04 Sep, 2026 | Seshadri Neervannan | Chief Operating Officer | Disposed S | 4,564 | $85.00 | $387.94K | 78,532 | Direct |
| 04 Sep, 2026 | Elizabeth Yeu Lin | Chief Medical Officer | Disposed S | 5,386 | $90.00 | $484.74K | 2,547 | Direct |
| 04 Sep, 2026 | Bobak R. Azamian | President/Ceo And Board Chair | Disposed S | 2,900 | $91.27 | $264.68K | 827,991 | Indirect |
| 04 Sep, 2026 | Elizabeth Yeu Lin | Chief Medical Officer | Disposed S | 1,590 | $85.00 | $135.15K | 3,180 | Indirect |
| 04 Sep, 2026 | Elizabeth Yeu Lin | Chief Medical Officer | Disposed S | 1,590 | $90.00 | $143.10K | 1,590 | Indirect |
| 02 Sep, 2026 | Bobak R. Azamian | President/Ceo And Board Chair | Disposed S | 10,000 | $80.06 | $800.60K | 837,991 | Indirect |
| 01 Sep, 2026 | Elizabeth Yeu Lin | Chief Medical Officer | Disposed S | 4,601 | $73.86 | $339.83K | 18,707 | Direct |
| 02 Sep, 2026 | Elizabeth Yeu Lin | Chief Medical Officer | Disposed S | 5,387 | $80.00 | $430.96K | 13,320 | Direct |
| 02 Sep, 2026 | Elizabeth Yeu Lin | Chief Medical Officer | Disposed S | 1,590 | $80.00 | $127.20K | 4,770 | Indirect |